Hybrid Molecules of Azithromycin with Chloramphenicol and Metronidazole: Synthesis and Study of Antibacterial Properties.
Inna A VolynkinaElena N BychkovaAnastasiia O KarakchievaAlexander S TikhomirovGeorge V ZatonskySvetlana E SolovievaMaksim M MartynovNatalia E GrammatikovaAndrey G TereshchenkovAlena PaleskavaAndrey L KonevegaPetr V SergievOlga A DontsovaIlya A OstermanAndrey E ShchekotikhinAnna N TevyashovaPublished in: Pharmaceuticals (Basel, Switzerland) (2024)
The sustained rise of antimicrobial resistance (AMR) causes a strong need to develop new antibacterial agents. One of the methods for addressing the problem of antibiotic resistance is through the design of hybrid antibiotics. In this work, we proposed a synthetic route for the conjugation of an azithromycin derivative with chloramphenicol and metronidazole hemisuccinates and synthesized two series of new hybrid molecules 4a - g and 5a - g . While a conjugation did not result in tangible synergy for wild-type bacterial strains, new compounds were able to overcome AMR associated with the inducible expression of the ermC gene on a model E. coli strain resistant to macrolide antibiotics. The newly developed hybrids demonstrated a tendency to induce premature ribosome stalling, which might be crucial since they will not induce a macrolide-resistant phenotype in a number of pathogenic bacterial strains. In summary, the designed structures are considered as a promising direction for the further development of hybrid molecules that can effectively circumvent AMR mechanisms to macrolide antibiotics.